Suppression of natural killer cells in the presence of CD34+ blood progenitor cells and peripheral blood lymphocytes  by Clausen, J. et al.
S
C
L
I
a
t
v
J
t
s
S
Biology of Blood and Marrow Transplantation 10:691-697 (2004)
 2004 American Society for Blood and Marrow Transplantation
1083-8791/04/1010-0004$30.00/0
doi:10.1016/j.bbmt.2004.06.009
Buppression of Natural Killer Cells in the Presence of
D34 Blood Progenitor Cells and Peripheral Blood
ymphocytes
J. Clausen, M. Enk, B. Vergeiner, K. Eisendle, A. L. Petzer, G. Gastl, E. Gunsilius
Laboratory of Tumor Biology & Angiogenesis, Division of Hematology & Oncology, Department of Internal
Medicine, University Hospital, Innsbruck, Austria
Correspondence and reprint requests: Dr. Eberhard Gunsilius, Division of Hematology & Oncology, Innsbruck
University Hospital, Anichstr. 35, 6020 Innsbruck, Austria (e-mail: eberhard.gunsilius@uibk.ac.at).
Received March 3, 2004; accepted June 15, 2004
ABSTRACT
Mobilization of CD34 peripheral blood progenitor cells (PBPCs) with granulocyte-colony stimulating factor
(G-CSF) may induce functional alterations in peripheral blood lymphocyte (PBL) subsets. We and others have
shown that natural killer (NK) cells from PBPC collections are less expandable in vitro than those obtained
during steady-state hematopoiesis. We show here that the extent of this proliferation deficit is related to the
number of circulating CD34 cells in vivo at the time of PBPC apheresis. Likewise, addition of autologous
CD34 cells to unseparated PBL reduced the expansion of the NK-cell subset by 22.2%  6.0% (n  10; P
<.005). In contrast, when using purified NK cells, their proliferation remained unimpaired by autologous
CD34 cells. Supernatants from CD34 cells cultured with autologous PBLs had an inhibitory effect on
proliferation of purified NK cells (n  16; P  .03), indicating that an interaction between CD34 cells and
lymphocytes is essential for the suppressive effect on NK cells. To investigate the role of T cells in this
interaction, intracellular cytokines were determined in T cells cultured for 7 days with or without autologous
CD34 cells. When cultured with CD34 cells, the frequency of IL-2–producing CD4 and CD8 T cells was
reduced by 19% and 24%, respectively, compared with T cells cultured alone (n  7; P  .016). Interferon-
–producing T cells were slightly reduced (P not statistically significant [ns]). Finally, the influence of T cells
and NK cells on the recovery of myeloid colony-forming cells (CFU-GMs) from purified CD34 cells was
examined. In the presence of T cells, 16%  6% of the input CFU-GM recovered after 7 days, compared with
5%  4% in the presence of NK cells (n  5; P  ns). Our findings point to an inhibition of NK-cell
proliferation mediated by an interaction of CD34 cells and T cells occurring during PBPC mobilization with
G-CSF.
© 2004 American Society for Blood and Marrow Transplantation
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sNTRODUCTION
High-dose chemotherapy (HDCT) followed by
utologous peripheral blood progenitor cell transplan-
ation (PBPCT) is widely used for the treatment of
ariety of malignancies. However, residual chemore-
.C. received ﬁnancial support from AMGEN, Vienna, Austria, and from
he Tiroler Verein zur Förderung der Krebsforschung an der Univer-
itätsklinik Innsbruck. B.V. was supported by the Hans und Blanca Moserstiftung, Austria.
B&MTistant neoplastic cells frequently cause a relapse of the
isease. Because chemoresistant tumor cells are not
ecessarily cross-resistant to an immune attack [1],
timulation of cytotoxic effector cells after PBPC au-
ografting is an attractive approach for the eradication
f minimal residual disease. Yet, long-lasting quanti-
ative and functional alterations can be observed in
atural killer (NK) cells and T cells after PBPCT
2,3]. This disturbed recovery of the cellular immune
ystem after PBPCT may be due in part to its recon-
titution by functionally impaired lymphocytes trans-
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6erred with the PBPC autograft. In fact, T cells con-
ained in PBPC harvests have a reduced proliferative
otential [4]. In addition, we and others have recently
eported the decreased expandability of NK cells ob-
ained at the time of PBPC mobilization [5-7]. We
ypothesized that mobilized CD34 PBPCs them-
elves might impair NK-cell functions, and thus in-
estigated the relationship between the number of
irculating CD34 cells in vivo and the proliferative
otential of NK cells contained within the PBPC
roducts. Furthermore, we examined the potential of
D34 cells to suppress the growth of NK cells in
itro, as well as the role of T lymphocytes in this
otential interaction.
ATERIALS AND METHODS
atients
PBPC samples (.5 mL) and peripheral blood (PB)
amples (10 mL) were obtained after informed con-
ent from patients with breast cancer (n  10) or
ymphoma (n  7), undergoing HDCT and autolo-
ous (or syngeneic; n  1) PBPCT. PBPCs were
obilized by chemotherapy (epirubicin plus paclitaxel
or breast cancer; high-dose cytosine arabinoside plus
is-platinum for lymphoma) and subsequent adminis-
ration of granulocyte-colony stimulating factor (G-
SF) (10 g/kg/day subcutaneously). All patients with
reast cancer were treated according to a study pro-
ocol approved by the local ethical committee.
ealthy, age-matched females (n  6) served as con-
rol subjects.
ell Separation and Culture Conditions
CD34 cells were immunomagnetically separated
rom freshly harvested or cryopreserved PBPCs after
ensity centrifugation and depletion of monocytes by
lastic adherence. Nonadherent MNCwere incubated
ith CD34 MicroBeads (MACS; Miltenyi Biotec,
ergisch Gladbach, Germany), and CD34 cells were
solated on RS columns (Miltenyi Biotech). MACS-
eparated CD34 cells were 96.0%  1.6% pure
mean  standard error under the mean [SEM]).
Peripheral blood lymphocytes (PBLs) were ob-
ained from PB or from PBPC products by prepara-
ion of mononuclear cells (MNCs) using density cen-
rifugation, and subsequent depletion of monocytes by
lastic adherence. For isolation of CD3 T cells, PBL
ere incubated with ﬂuorescein isothiocyanate
FITC)-conjugated CD3 monoclonal antibody (mAb)
Becton Dickinson, San Jose, CA), secondary labeled
ith anti-FITC MicroBeads (Miltenyi), and separated
n MACS columns. NK cells were separated by ﬂuo-
escence-activated cell sorting on a FACSVantage
Becton Dickinson). For this, monocyte-depleted
NCs were labeled with CD56-FITC mAb and 7
92D3-PE mAb (both from Becton Dickinson). The
ean purity of T cells (CD3) and NK cells (CD56/
D3) was 98.7% .2% and 97.3% 1.2%, respec-
ively. All cell cultures were performed with complete
edium (CM) as described previously [6].
Puriﬁed cells (ie, CD34, PBLs, NK cells, T cells)
ere used for the subsequently described experiments,
ncluding expansion cultures, proliferation assays,
eneration of supernatants, and colony-formation as-
ays.
low Cytometry
Cells were phenotypically analyzed on a FACScan
ytometer (Becton Dickinson). For quantiﬁcation of
K cells, anti–CD56-FITC (Becton Dickinson) was
sed in combination with either anti–CD3-PE (Bec-
on Dickinson) or anti–CD3-RPE-Cy5 (Dako,
lostrup, Denmark). The purity of separated CD34
BPCs was determined using anti–CD34-PE (Becton
ickinson). Peripheral blood CD34 cell counts were
xamined immediately before apheresis using the
tandard method for clinical purposes. Brieﬂy, cells
ere stained with anti–CD45-FITC and anti–
D34-PE (both from Becton Dickinson). After lysis
f erythrocytes, the proportion of CD34 cells was
nalyzed within the gate of all CD45 cells. The
umber of CD34 cells (given as cells per L) was
alculated from the patient’s white blood count and
roportion of CD34 cells.
orrelation of in vivo CD34 Cell Counts and
K-Cell Expandability In Vitro
PBLs were derived from G-CSF–mobilized
BPC collections from women with breast cancer
n  10). The PBLs were cultured for 14 days in the
resence of interleukin (IL)-2 (1000 U/mL) as de-
cribed previously [6]. The expansion of CD56
ymphocytes was calculated on the basis of the total
ell expansion and the proportion of CD56 cells as
etermined by ﬂow cytometry. The correlation be-
ween CD56 cell expansion rates in vitro and
D34 cell counts in vivo was calculated by Pear-
on statistics. The in vitro NK-cell expansion rates
ere compared between patients with CD34 cell
ounts 100 per L of blood at the day of apheresis
n  5), patients with 100 CD34 cells per L (n
5), and untreated control subjects (n  6) (Mann-
hitney nonparametric test for unpaired samples).
xpansion of Purified and Nonpurified NK Cells in
he Presence or Absence of Autologous CD34
ells
PBLs were obtained from peripheral blood of fe-
ales with breast cancer at a minimum of 1 week after
he PBPC collection (n 10). PBLs were cultured for
days with IL-2 (1000 U/mL), either without or with
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NK-Cell Suppression During CD34 Cell Mobilization
B% or 20% of previously cryopreserved and puriﬁed
utologous CD34 cells. The numerical expansion of
K cells was calculated on the basis of the total cell
xpansion and the percentage of CD56CD3 cells.
In 6 additional experiments, puriﬁed CD56CD3
K cells were used instead of unsorted PBL. As de-
cribed earlier, the NK cells were cultured for 7 days
ither in the presence or absence of autologous CD34
ells (1%, 10%, and 20% of the cell number).
roliferation of NK Cells in the Presence or
bsence of CD34 Cells
Puriﬁed NK cells obtained from peripheral blood of
atients with breast cancer (n  3) were plated in qua-
ruplicates in 96-well microtiter plates. A total of 2 
04 cells were seeded per well in 100 L CM with 1000
/mL rhIL-2. NK cells were cultured alone and in the
resence of 2000 and 4000 previously cryopreserved
utologous CD34 cells were added per well. On day 4,
ll cultures were supplemented with fresh rhIL-2. Be-
ween day 5 and day 6, 3H-thymidine (1 Ci per well)
as added. After 16-20 hours, all cells were harvested on
Filtermate 96 Harvester (Packard, Downers Grove,
L). The incorporation of 3H-thymidine was measured
n a TopCount Microplate Scintillation Counter (Pack-
rd).
K-Cell Proliferation in the Presence of
upernatant from CD34 Cells, PBLs, and CD34
ell/PBL Co-Cultures
For the generation of supernatants, PBLs and G-
SF–mobilized CD34 PBPCs were obtained from
atients undergoing PBPCT for lymphoma (n  4).
BLs and CD34 cells were cultured separately and
n co-cultures at 4  105 cells/mL in 4-well dishes
Nunc, Roskilde, Denmark). The co-cultures con-
isted of 80% PBLs and 20% CD34 cells. Then, 48
ours later, puriﬁed NK cells (n  16) from healthy
onors were plated in quadruplicate at each 2  104
ells/50 L into separate 96-well plates. From day 1
hrough day 5 of the NK-cell cultures, each 50 L of
upernatant (SN), from cultures containing either
BLs, CD34 cells, or both, or medium alone, was
dded to the puriﬁed NK cells. On day 5, 3H-thymi-
ine was added to the NK cells, and its incorporation
as measured as described earlier. Single experiments
or each group were compared with one another using
he nonparametric Mann-Whitney test.
etermination of Intracellular and Secreted
ytokines in CD4 and CD8 T Cells
T cells puriﬁed from PBs of patients undergoing
BPCT for lymphoma (n  7) were plated either
lone or in co-cultures consisting of T cells (80%) and
reviously cryopreserved autologous CD34 PBPCs
620%). Cells were plated at 1.5  10 total cells per a
B&MTL of CM in all cultures. From day 2 through day 6,
ach 40% of the SN was carefully removed, centri-
uged, cryopreserved for the determination of IL-10
evels by enzyme-linked immunosorbent assay
ELISA), and replaced by fresh medium. On day 6 of
he cultures, the number of lymphocytes with intra-
ytoplasmic expression of IL-2, IL-4, and interferon
IFN)-	 was determined by ﬂow cytometry. For that,
he cells were stimulated for 4 hours at 37°C in the
resence of 25 ng/mL phorbol-12-myristate-13-ace-
ate, 10 g/mL ionomycin, and 10 g/mL brefeldin-A
all from Sigma, St. Louis, MO). Subsequently, the
ells were stained for surface antigens using RPE-
y5–conjugated CD3 mAb (Dako) and either FITC-
r PE-conjugated CD8 mAb (Becton Dickinson). Af-
er washing, the cells were permeabilized and ﬁxed
sing the FIX&PERM Cell Permeabilization Kit (An
er Grub Bio Research, Kaumberg, Austria) accord-
ng to the manufacturer’s instructions. The following
Abs were used for intracellular staining: anti-human
NF-	–FITC, anti-human IL-2–PE, and anti-human
L-4–PE (all from Becton Dickinson). IgG1-PE and
gG2a-FITC (both from Becton Dickinson) were used
or appropriate isotype controls. After staining, cells
ere washed with FacsFlow solution (Becton Dickin-
on) containing .5% bovine serum albumin and .1%
aN3, then analyzed on a FACScan (Becton Dickin-
on). The expression of intracellular cytokines was
xamined by separate gating of the CD3CD8 (Th)
nd the CD3CD8 (Tc) lymphocyte populations,
espectively.
For determination of IL-10 concentrations in SN
rom T-cell and PBPC (co-)cultures, an ELISA kit
Cytoscreen Human IL-10 Ultra Sensitive; Bio-
ource, Camarillo, CA) was used according to the
anufacturer’s instructions.
ssay for Colony-Forming Cells with CD34
BPCs after Culture with Either T Cells or NK
ells
Puriﬁed CD34 cells (5  104) from PBPC prod-
cts were cultured for 7 days with separated autolo-
ous T cells or NK cells, each 5  105 (n  5). The
umber of granulocyte/macrophage colony-forming
nits (CFU-GMs) was determined before and after
he co-cultures using an established CFC assay [8].
he CFU-GM recovery (in %) is given as the output
FU-GM count (day 7) in relation to the input
FU-GM count (day 0).
tatistics
If not otherwise indicated, NK-cell expansion
ates and proliferation indices were compared using
he nonparametric Wilcoxon test for matched pairs.
he correlation between CD56 cell expansion rates
nd CD34 cell numbers in PB was calculated by
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6earson statistics. All statistics were performed using
raphPad software.
ESULTS
nverse Correlation between CD34 Cell Counts
n vivo and the Expandability of NK Cells in vitro
We have previously reported that the in vitro
xpandability of NK cells from G-CSF–mobilized
BPC products is reduced compared with that of
K-cells obtained during steady state hematopoiesis
6]. Now we show that the extent of this growth
nhibition is more pronounced in patients with high
D34 cell counts (NK-cell expansion, 13.3  4.1-
old for patients with100 CD34 cells/L vs 95.5
3.4-fold in controls; P  .005), compared with pa-
ients with 100 CD34 cells/L, in whom no sig-
iﬁcant difference was found compared with controls
31.8  10.1-fold expansion; P  .08 vs controls)
Figure 1A). The expandability of CD56 cells in
itro was not inﬂuenced by the number of monocytes
n the PBPC products (r  .37; P  .29).
xpansion of NK Cells in PBL Bulk Cultures in the
resence of Autologous CD34 Cells
To investigate whether the foregoing observa-
ion is reproducible in vitro, we added autologous
D34 cells to lymphocyte cultures at 2% of the
otal cell number (representing the upper range of
D34 cell counts in the apheresis products). To
urther address the dose-response relationship, we
lso added CD34 cells at 20%. Within PBL bulk
ultures (n  10), the CD56CD3 NK-cell pop-
lation expanded 4.8  1.5-fold during 7 days.
hen autologous CD34 cells were added to the
BL cultures at 2% and 20% of the cell number, the
K-cell expansion was similarly reduced to 3.3 
.4-fold (P  .02) and 3.1  .9-fold (P  .004),
espectively (Figure 1B).
xpansion and Proliferation of Purified NK Cells in
he Presence of Autologous CD34 Cells
To examine whether the suppressive effect of
D34 cells is directly exerted to NK cells or is
ediated by T cells within the bulk cultures, we re-
pplied our experiment with puriﬁed NK cells instead
f bulk lymphocyte cultures (n  6). In contrast to
K cells within PBL bulk cultures, the mean numer-
cal expansion of puriﬁed NK cells was not impaired,
ut rather was unchanged (by a factor of 1.0) or even
nhanced (by factors of 1.3 and 1.2) when CD34
ells were added at 1%, 10%, and 20% CD34 cells,
espectively (P  .7, .4, and .5; no signiﬁcant differ-
nce for all 3 ratios). To substantiate this ﬁnding,
H-thymidine incorporation was measured in puriﬁed
K cells in the absence or presence of 10% or 20% N
94utologous CD34 cells. In accordance with the ﬁnd-
ngs from the expansion cultures, proliferation of pu-
iﬁed NK cells (9.7  7.5  103 cpm) was not dimin-
shed by the presence of CD34 cells (11.1  6.7 
03 cpm and 10.2  6.5  103 cpm for CD34 cells
dded at 10% and 20%, respectively; n  3).
K-Cell Proliferation in the Presence of
upernatants from CD34 Cells with or without
utologous PBL
Proliferation of puriﬁed NK cells (n  16) was
etermined in the presence of SNs from CD34 cells
lone, PBL alone, co-cultures of both cell types, and
edium. Neither SN from PBL alone nor from
D34 cells alone exerted a suppressive effect on

igure 1. A, Expansion (mean  SEM) of CD56 cells from PB of
ealthy females (control, n  6), and from PBPC collections from
atients in whom 100 CD34 cells/L PB (n  5) or 100
D34 cells/L (n  5) were measured at the day of apheresis. *P
.08 versus control (ns); **P .005 versus control (nonparametric
ann-Whitney test for unpaired samples). B, Expansion (mean 
EM) of NK cells within bulk PBL cultures in the presence or
bsence of autologous CD34 PBPCs (n  10 for each experimen-
al set). *P .05; **P .005 compared with PBL cultures without
D34 cells (nonparametric Wilcoxon test for matched pairs).K-cell proliferation. In contrast, SN from CD34
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NK-Cell Suppression During CD34 Cell Mobilization
Bells even enhanced the growth of NK cells compared
o medium (P  .002). However, in the presence of
N from CD34/PBL co-cultures, NK-cell prolifer-
tion was signiﬁcantly reduced compared to SN from
D34 cells alone (P  .03) and tended to be lower
ompared to SN from PBL alone (P  ns) (Table 1).
hus, the supportive effect of SN from CD34 cells
n NK-cell proliferation was virtually abrogated when
he CD34 cells were co-cultured with blood lympho-
ytes, despite the fact that SN from lymphocytes
lone, similar to CD34 cells alone, enhanced NK-
ell proliferation.
ytokine Production in T Cells Cultured with or
ithout CD34 PBPC
To investigate whether autologous CD34 cells
ay inﬂuence Th1 (ie, IL-2 and IFN-	) and Th2 (ie
L-4 and IL-10) cytokine production in T cells,
able 1. Proliferation of Puriﬁed NK Cells in the Presence of SN
rom Separately Cultured or Co-Cultured PBL and CD34 Cells
Source of SN
CD34/PBL
Co-culture
CD34
Cells PBL Medium
K-cell
proliferation 2.9  .8 4.0  .5 3.7  .4 2.4  .3
value
(vs co-culture) - .03 ns ns
p  1,000 cpm/20,000 cells.
igure 2. Proportion of (A) IL-2–, (B) IFN-	–, and (C) IL-4–pro
ncubation without or with autologous CD34 cells, respectively (n
uriﬁed T cells, puriﬁed CD34 cells, and from co-cultures of T ce
igniﬁcant differences.
B&MTuriﬁed T cells were cultured alone and with autol-
gous CD34 cells (n  7). After 7 days, determi-
ation of intracellular cytokines by ﬂow cytometry
evealed a consistent decrease in the number of
L-2–producing cells in both the CD8 and CD4
-cell subsets (P  .016 for both subsets; Figure
A). In addition, the proportion of IFN-	–produc-
ng cells tended to be reduced in both T-cell subsets
Figure 2B). The proportion of IL-4–producing
ells was not signiﬁcantly altered (Figure 2C). IL-10
evels were similar in PBL cultures with and without
D34 cells (range, 0–7 pg/mL, not different) and
irtually absent in SN from CD34 cells alone
Figure 2D).
ecovery of CFU-GM from CD34 PBPCs
ultured with Autologous T Cells or NK Cells
To investigate the inﬂuence T cells and NK cells
n maintenance and proliferation of myeloid progen-
tor cells (CFU-GM) in vitro, CD34 PBPCs were
ultured for 7 days with autologous T cells or NK
ells. After culture with autologous T cells, 16.9% 
.9% of the input CFU-GM number was recovered,
hereas in the presence of NK cells, the CFU-GM
ontent decreased to 5.4%  4.0% of the input value
Figure 3) (n  5; P  .12; Wilcoxon test for matched
airs).
CD8 T cells (solid bars) and CD4 T cells (hatched bars), after
, IL-10 concentrations (pg/mL; mean SEM) in supernatants from
autologous CD34 cells (n  6). P values are indicated in cases ofducing
7). D
lls and695
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6ISCUSSION
G-CSF–mobilized PBPCs are widely used for al-
ogeneic and autologous hematopoietic progenitor
ell transplantation. Despite the fact that PBPC grafts
ontain signiﬁcantly higher numbers of T cells than
one marrow grafts, the incidence and severity of
cute graft-versus-host disease after PBPC transplan-
ation is not increased in a corresponding extent
9-11]. This ﬁnding suggests an impaired, or altered,
mmune competence of the effector cells transferred
ith the G-CSF–primed peripheral blood allografts.
ikewise, after autologous PBPC retransfusion, long-
asting quantitative and functional impairment can be
bserved in T-lymphocyte subsets [3,6,7,12].
We observed an inverse relationship between the
roliferative capacity of NK cells in vitro and the
umber of circulating CD34 cells in peripheral
lood at the time of PBPC harvesting. Thus, we
imed to investigate whether the mobilized CD34
ells themselves may contribute to the inhibition of
K cells. Indeed, we found that the assumed suppres-
ive effect of CD34 cells on NK cells in vivo can be
eproduced in vitro, provided that NK cells are ap-
lied within PBL bulk cultures (consisting of ﬁcoll-
eparated and monocyte-depleted peripheral blood
NC). In contrast, in the case of puriﬁed NK cells,
D34 cells failed to inhibit their proliferation in
itro. These ﬁndings suggest that the suppressive ef-
ect of CD34 cells requires the presence of blood
ymphocytes other than NK cells. Accordingly, we
ound that SN from co-cultures of CD34 cells with
utologous PBL, but not SN from separately cultured
BL or CD34 cells, diminished the proliferation of
uriﬁed NK cells. Thus, we investigated the possibil-
ty that T lymphocytes are the candidate mediators of

igure 3. Puriﬁed CD34 cells were cultured with autologous NK
ells and T cells for 1 week. The percent CFU-GM recovery (ie, the
FU-GM outcome after 1 week in proportion to the input
FU-GM numbers) is given as mean  SEM (n  5; P  ns;
ilcoxon matched-pairs test).D34 cell–induced inhibition of NK cells. Because m
96he Th1-type cytokines, IL-2 and IFN-	, have potent
timulatory effects on NK cells, whereas Th2-type
ytokines, such as IL-4 and IL-10, have a negative
egulatory effect on the development of cytotoxic ef-
ector cells including NK cells [13-17], we analyzed
he cytokine production in T cells in the presence or
bsence of autologous CD34 cells. In fact, in the
resence of autologous CD34 cells, we found a sig-
iﬁcant decrease of IL-2–producing T cells. Though
hanges in the production of IFN-	, IL-4, and IL-10
n T cells did not reach signiﬁcance, the diminished
umber of IL-2–producing T cells in the presence of
D34 cells indicates a cytokine shift that may con-
ribute to the suppression of NK-cell proliferation on
BPC mobilization by G-CSF. Even if this shift is not
ast on a quantity basis (although signiﬁcant), it may
e interpreted as an indicator for a more complex
echanism additionally comprising as-yet unidenti-
ed processes.
G-CSF has no direct inhibitory effect on NK cells
5], and CD34 cells themselves do not produce
L-10 or G-CSF [18]. However, increased production
f IL-10 by monocytes on treatment with G-CSF,
hich has been shown to impair T-cell proliferation
4], is likely to inﬂuence NK-cell proliferation as well.
lso, it is possible that not only modulation of T-cell
unctions by the autologous CD34 cells, but also,
ice versa, stimulation of CD34 cells and their my-
loid progeny by T-cell cytokines are contributing to
ur ﬁndings. Thus, to further elucidate the T cell–
D34 cell interaction involved in NK-cell suppres-
ion, we examined the recovery of myeloid progeni-
ors (CFU-GM) from CD34 cells cultured with T
ells or NK cells. We hypothesized that maintenance
f CD34 myeloid progenitor cells is supported by T
ells rather than by NK cells, which would addition-
lly contribute to the suppressive impact of the
D34 cell–T cell interaction, that is, by the promo-
ion of myelo-monocytic progeny with an assumed
irect inhibitory effect on NK cells. In a series of 5
xperiments, a 3 -fold higher recovery of CFU-GM
as found when CD34 cells were cultured with T
ells compared with NK cells. Due to the limitation of
vailable cellular material, the size of this series was
ot sufﬁcient to demonstrate a signiﬁcant difference.
G-CSF has recently been shown to stimulate the
roduction of type-2 cytokines in T cells, both via a
irect effect on CD4 T cells and by a mechanism
nvolving polarization of dendritic cells [19-22]. Thus,
n addition to the established monocyte-mediated ef-
ects [4], other mechanisms that modulate T-cell cy-
okines are likely to be responsible for the impaired
roliferative capacity of NK cells and T cells after the
pplication of G-CSF in vivo. Our data suggest an
dditional mechanism, involving an interaction of
D34 cells with T lymphocytes, by which PBPC
obilization with G-CSF may affect innate immune
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NK-Cell Suppression During CD34 Cell Mobilization
Bunctions in vivo. Our hypothesis of a bidirectional,
mmunosuppressive interaction between CD34 pro-
enitor cells and T cells has recently been supported
y a report on mesenchymal stem cells that, after
riming by splenocytes, mediate immunosuppression
ia CD8 T cells in a subsequent step [23].
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